Brazier John, Akehurst Ron, Brennan Alan, Dolan Paul, Claxton Karl, McCabe Chris, Sculpher Mark, Tsuchyia Aki
Health Economics and Decision Science, University of Sheffield, Sheffield, UK.
Appl Health Econ Health Policy. 2005;4(4):201-8. doi: 10.2165/00148365-200504040-00002.
Currently, health state values are usually obtained from members of the general public trying to imagine what the state would be like rather than by patients who are actually in the various states of health. Valuations of a health state by patients tend to vary from those of the general population, and this seems to be due to a range of factors including errors in the descriptive system, adaptation to the state and changes in internal standards. The question of whose values are used in cost-effectiveness analysis is ultimately a normative one, but the decision should be informed by evidence on the reasons for the differences. There is a case for obtaining better informed general population preferences by providing more information on what it is like for patients (including the process of adaptation).
目前,健康状态值通常是由普通公众成员试图想象该状态会是什么样而获得的,而非由处于各种健康状态的患者获得。患者对健康状态的估值往往与普通人群的估值不同,这似乎是由一系列因素导致的,包括描述系统中的误差、对该状态的适应以及内部标准的变化。在成本效益分析中使用谁的估值最终是一个规范性问题,但该决定应以关于差异原因的证据为依据。有理由通过提供更多关于患者情况(包括适应过程)的信息来获得更明智的普通人群偏好。